{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:39:26Z","timestamp":1775705966859,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jiph.2020.10.012","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T08:20:47Z","timestamp":1603786847000},"page":"495-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Combating COVID-19: The role of drug repurposing and medicinal plants"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-3403","authenticated-orcid":false,"given":"Shah A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Al-Balushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2020.10.012_bib0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10.1016\/j.jiph.2020.10.012_bib0010","first-page":"11","article-title":"The origin, transmission and clinical therapies oncoronavirus disease 2019 (COVID-19) outbreak \u2014 an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0015","first-page":"1","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0020","unstructured":"https:\/\/www.worldometers.info\/coronavirus\/. [Accessed on 8th July 2020]."},{"key":"10.1016\/j.jiph.2020.10.012_bib0025","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/qjmed\/hcaa103","article-title":"Are certain drugs associated with enhanced mortality in COVID-19?","volume":"113","author":"Goldstein","year":"2020","journal-title":"QJM Int J Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"issue":"27","key":"10.1016\/j.jiph.2020.10.012_bib0040","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.2174\/0929867327666200416131117","article-title":"SARS-CoV-2: recent reports on antiviral therapies based on lopinavir\/ritonavir, darunavir\/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus","volume":"27","author":"Costanzo","year":"2020","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.jiph.2020.10.012_bib0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat corona virus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.jiph.2020.10.012_bib0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","article-title":"Drug targets for corona virus: a systematic review","volume":"52","author":"Prajapat","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jiph.2020.10.012_bib0055","series-title":"WHO launches global megatrial of the four most promising coronavirus treatments","author":"Kupferschmidt","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0065","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID\u201119): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiph.2020.10.012_bib0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jiph.2020.10.012_bib0075","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiph.2020.10.012_bib0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0090","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0095","series-title":"Potential coronavirus treatment granted rare disease status","author":"Perrone","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0100","series-title":"FDA announces two drugs given \u2018compassionate use\u2019 status in treating COVID-19","author":"Coppock","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0105","series-title":"Frequently asked questions on the emergency use authorization for remdesivir for certain hospitalized COVID-19 patients (PDF)","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0110","series-title":"Coronavirus (COVID-19) update: FDA warns of newly discovered potential drug interaction that may reduce effectiveness of a COVID-19 treatment authorized for emergency use","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARSCoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0120","unstructured":"U.S. National Library of Medicine: recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treatment for patients with COVID-19 (APN01-COVID-19). ClinicalTrials. gov identifier: NCT04335136. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04335."},{"key":"10.1016\/j.jiph.2020.10.012_bib0125","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","volume":"75","author":"Zhou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2020.10.012_bib0130","first-page":"E019","article-title":"Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia [in Chinese]","volume":"43","author":"Multicenter Collaboration Group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.jiph.2020.10.012_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105945","article-title":"Aminoquinolines against Coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine","volume":"55","author":"Sahraei","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"15","key":"10.1016\/j.jiph.2020.10.012_bib0140","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquineforthe treatment of severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2020.10.012_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2020.10.012_bib0150","series-title":"No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19. Recovery trial","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0155","series-title":"Hydroxychloroquine halted in WHO-sponsored COVID-19 trials","author":"Mulier","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0160","unstructured":"Progress of the small sample clinical trial of Ganovo\u00ae and Ritonavir combination therapy on novel Coronavirus Pneumonia. http:\/\/ascletis.com\/news_detail\/172\/id\/348.html. [Accessed on 4th April 2020]."},{"key":"10.1016\/j.jiph.2020.10.012_bib0165","unstructured":"News. http:\/\/www.szdsyy.com\/News\/0a6c1e58-e3d0-4cd1-867a-d5524bc59cd6.html. [Accessed on 28th March 2020]."},{"key":"10.1016\/j.jiph.2020.10.012_bib0170","series-title":"Russian Ministry of Health approves the first COVID-19 drug Avifavir produced by JV of RDIF and ChemRar","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0175","series-title":"Glenmark\u2019s FabiFlu approved for coronavirus treatment in India, costs Rs 103 per tablet","year":"2020"},{"issue":"25","key":"10.1016\/j.jiph.2020.10.012_bib0180","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.1021\/jp102619w","article-title":"Membranotropic effects of arbidol, a broad anti-viral molecule, on phospholipid model membranes","volume":"114","author":"Villala\u00edn","year":"2010","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.jiph.2020.10.012_bib0185","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against corona virus disease 2019: a retrospective cohort study","volume":"81","author":"Deng","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2020.10.012_bib0190","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1093\/jac\/dkw338","article-title":"A review of treatment modalities for Middle East Respiratory Syndrome","volume":"71","author":"Mo","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2020.10.012_bib0195","unstructured":"SARS-COV-2 antiviral therapy. Stanford University Coronavirus Antiviral Research Database. https:\/\/covdb.stanford.edu\/page\/covid-review\/. [Accessed on 25th June 2020]."},{"issue":"10223","key":"10.1016\/j.jiph.2020.10.012_bib0200","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (Lond Engl)"},{"issue":"3","key":"10.1016\/j.jiph.2020.10.012_bib0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-020-01590-2","article-title":"Drug repurposing against COVID-19: focus on anticancer agents","volume":"39","author":"Ciliberto","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jiph.2020.10.012_bib0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2020.10.012_bib0220","series-title":"NIH clinical trial of investigational vaccine for COVID-19 begins","author":"National Institutes of Health","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0225","series-title":"Potential COVID-19 therapeutics currently in development","author":"Cahill","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0230","series-title":"WHO launches global megatrial of the four most promising coronavirus treatments","author":"Kupferschmidt","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0235","series-title":"Nuffield department of population health","author":"RECOVERY trial rolled out across the U.K","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0240","series-title":"Coronavirus: world\u2019s biggest trial of drug to treat Covid-19 begins in UK","author":"Boseley","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0245","series-title":"Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 (PDF)","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0250","series-title":"The plant that might stop Covid-19","year":"2020"},{"key":"10.1016\/j.jiph.2020.10.012_bib0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2013.10.013","article-title":"Ecology, evolution and classification of bat corona viruses in the aftermath of SARS","volume":"101","author":"Drexler","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0260","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.bmcl.2012.04.081","article-title":"Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13","volume":"22","author":"Yu","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jiph.2020.10.012_bib0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.antiviral.2012.03.006","article-title":"EPs\u00ae 7630 (Umckaloabo\u00ae), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo","volume":"94","author":"Theisen","year":"2012","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0270","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1472-6882-12-214","article-title":"Novel antiviral activity of baicalein against dengue virus","volume":"12","author":"Zandi","year":"2012","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0275","unstructured":"Diagnosis and treatment of pneumonia caused by 2019-nCoV (version 5). http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202002\/3b09b894ac9b4204a79db5b8912d4440.shtml. [Accessed on 25th March 2020]."},{"issue":"2","key":"10.1016\/j.jiph.2020.10.012_bib0280","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.joim.2020.02.005","article-title":"In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus","volume":"18","author":"Zhang","year":"2020","journal-title":"J Integr Med"},{"issue":"4","key":"10.1016\/j.jiph.2020.10.012_bib0285","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"Qamar","year":"2020","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.jiph.2020.10.012_bib0290","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3382\/ps\/pew069","article-title":"Synergistic effects of thymoquinone and curcumin on immune response and anti-viral activity against avian influenza virus (H9N2) in turkeys","volume":"95","author":"Umar","year":"2016","journal-title":"Poult Sci"},{"key":"10.1016\/j.jiph.2020.10.012_bib0295","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0192-0561(00)00036-9","article-title":"Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection","volume":"22","author":"Salem","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.jiph.2020.10.012_bib0300","doi-asserted-by":"crossref","first-page":"144","DOI":"10.21010\/ajtcam.v13i6.20","article-title":"Selective inhibition of hepatitis c virus replication by alpha-zam, a Nigella sativa seed formulation","volume":"13","author":"Oyero","year":"2016","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0305","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3748\/wjg.v19.i16.2529","article-title":"Effects of Nigella sativa on outcome of hepatitis C in Egypt","volume":"19","author":"Barakat","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jiph.2020.10.012_bib0310","first-page":"332","article-title":"Nigella sativa concoction induced sustained seroreversion in HIV patient","volume":"10","author":"Onifade","year":"2013","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jdermsci.2007.05.009","article-title":"Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: analysis of the molecular mechanisms involved","volume":"47","author":"Baroni","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jiph.2020.10.012_bib0320","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ptr.2650040305","article-title":"Antiviral activity of the infusion (SHS-174) from flowers of Sambucus nigra L., aerial parts of Hypericum perforatum L., and roots of Saponaria officinalis L. against influenza and herpes simplex viruses","volume":"4","author":"Serkedjieva","year":"1990","journal-title":"Phytother Res"},{"issue":"9\u201310","key":"10.1016\/j.jiph.2020.10.012_bib0325","first-page":"359","article-title":"Anti-viral effects of aqueous extracts of Aloe ferox and Withania somnifera on herpes simplex virus type 1 in cell culture","volume":"103","author":"Kambizi","year":"2007","journal-title":"S Afr J Sci"},{"issue":"3","key":"10.1016\/j.jiph.2020.10.012_bib0330","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12013-015-0524-9","article-title":"Promising anti-influenza properties of active constituent of Withania somnifera ayurvedic herb in targeting neuraminidase of H1N1 influenza: computational study","volume":"72","author":"Cai","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.jiph.2020.10.012_bib0335","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2007.03.010","article-title":"Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin-carbohydrate complex from Prunella vulgaris","volume":"75","author":"Zhang","year":"2007","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068992","article-title":"Antiviral activity of glycyrrhizin against hepatitis C virus in vitro","volume":"8","author":"Matsumoto","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2020.10.012_bib0345","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1479-5876-9-112","article-title":"Glycyrrhizin as antiviral agent against hepatitis C virus","volume":"9","author":"Shfaq","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0350","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1128\/JVI.00789-12","article-title":"HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication","volume":"86","author":"Moisy","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jiph.2020.10.012_bib0355","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/ptr.5189","article-title":"Autophagy activation and antiviral activity by a licorice triterpene","volume":"28","author":"Laconi","year":"2014","journal-title":"Phytother Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0360","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jac\/dkg291","article-title":"In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids","volume":"52","author":"Chiang","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jiph.2020.10.012_bib0365","first-page":"506","article-title":"A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus","volume":"6","author":"Moradi","year":"2016","journal-title":"Avicenna J Phytomed"},{"key":"10.1016\/j.jiph.2020.10.012_bib0370","doi-asserted-by":"crossref","first-page":"27539","DOI":"10.1038\/srep27539","article-title":"Curcumin inhibits HIV-1 by promoting Tat protein degradation","volume":"6","author":"Ali","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2020.10.012_bib0375","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.febslet.2009.12.019","article-title":"Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway","volume":"584","author":"Kim","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jiph.2020.10.012_bib0380","first-page":"1341","article-title":"Anti-avian influenza virusH9N2 activity of aqueous extracts of Zingiber officinalis (Ginger) & Allium sativum (Garlic) in chick embryos","volume":"30","author":"Rasool","year":"2017","journal-title":"Pak J Pharm Sci"},{"issue":"2","key":"10.1016\/j.jiph.2020.10.012_bib0385","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jphp.12669","article-title":"A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms","volume":"69","author":"Amber","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jiph.2020.10.012_bib0390","first-page":"3422","article-title":"COVID-19: emerging protective measures","volume":"24","author":"Balachandar","year":"2020","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"10.1016\/j.jiph.2020.10.012_bib0395","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2020.1760136","article-title":"Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach","author":"Enmozhi","year":"2020","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"10.1016\/j.jiph.2020.10.012_bib0400","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00705-016-3166-3","article-title":"Broad-spectrum antiviral properties of Andrographolide","volume":"162","author":"Gupta","year":"2016","journal-title":"Arch Virol"},{"issue":"5","key":"10.1016\/j.jiph.2020.10.012_bib0405","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jmv.25707","article-title":"Potential interventions for novel coronavirus in China: a systematic review","volume":"92","author":"Zhang","year":"2020","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.jiph.2020.10.012_bib0410","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/v8010006","article-title":"Quercetin as an antiviral agent inhibits influenza a virus (IAV) entry","volume":"8","author":"Wu","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2020.10.012_bib0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049493","article-title":"Inhibition of Angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies","volume":"7","author":"Guerrero","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jiph.2020.10.012_bib0420","first-page":"541","article-title":"Thymoquinone: shield and sword against SARS-CoV-2","volume":"3","author":"Sommer","year":"2020","journal-title":"Precis Nanomed"},{"key":"10.1016\/j.jiph.2020.10.012_bib0425","doi-asserted-by":"crossref","first-page":"100382","DOI":"10.1016\/j.hermed.2020.100382","article-title":"Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19","volume":"23","author":"Rahman","year":"2020","journal-title":"J Herb Med"},{"issue":"4","key":"10.1016\/j.jiph.2020.10.012_bib0430","first-page":"e121","article-title":"Drug repositioning for the prophylaxis and treatment of COVID-19","volume":"8","author":"Al-Noaemi","year":"2020","journal-title":"J Cardiol Res Rev Rep"},{"key":"10.1016\/j.jiph.2020.10.012_bib0435","article-title":"Molecular docking, simulation and MM-PBSA studies of Nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment","author":"Ahmad","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jiph.2020.10.012_bib0440","unstructured":"NIH, US National Library of Medicine. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04347382. [Accessed on 7th July 2020]."},{"key":"10.1016\/j.jiph.2020.10.012_bib0445","unstructured":"NIH, US National Library of Medicine. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04401202. [Accessed on 7 July 2020]."},{"issue":"6","key":"10.1016\/j.jiph.2020.10.012_bib0450","first-page":"1","article-title":"Aloe vera and its components inhibit influenza A virus-induced autophagy and replication","volume":"47","author":"Jang-Gi","year":"2019","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.jiph.2020.10.012_bib0455","first-page":"49","article-title":"Assessment of anti HSV-1 activity of Aloe vera gel extract: an in vitro study","volume":"17","author":"Rezazadeh","year":"2016","journal-title":"J Dent Shiraz Univ Med Sci"},{"key":"10.1016\/j.jiph.2020.10.012_bib0460","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-3542(01)00125-5","article-title":"In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus","volume":"49","author":"Semple","year":"2001","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiph.2020.10.012_bib0465","article-title":"A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence","author":"Li-sheng","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.jiph.2020.10.012_bib0470","first-page":"86","article-title":"European Aloe vera (L.) Burm. F. as a potential anti-COVID-19 plant: a mini-review of its antiviral activity","volume":"31","author":"Mpiana","year":"2020","journal-title":"J Med Plants"},{"key":"10.1016\/j.jiph.2020.10.012_bib0475","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2020.1764868","article-title":"Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants","author":"Gyebi","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jiph.2020.10.012_bib0480","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2020.1763199","article-title":"In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria","author":"Abdelli","year":"2020","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.jiph.2020.10.012_bib0485","first-page":"53","article-title":"Discovery of inhibitory materials against PEDV corona virus from medicinal plants","volume":"64","author":"Yang","year":"2016","journal-title":"Jpn J Vet Res"},{"issue":"4","key":"10.1016\/j.jiph.2020.10.012_bib0490","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.foodchem.2009.09.011","article-title":"Curcumin inhibits influenza virus infection and haemagglutination activity","volume":"119","author":"Chen","year":"2010","journal-title":"Food Chem"},{"key":"10.1016\/j.jiph.2020.10.012_bib0495","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jff.2017.12.017","article-title":"Antiviral potential of curcumin","volume":"40","author":"Mathew","year":"2018","journal-title":"J Funct Foods"},{"issue":"10","key":"10.1016\/j.jiph.2020.10.012_bib0500","doi-asserted-by":"crossref","first-page":"195","DOI":"10.31989\/ffhd.v10i5.707","article-title":"Mechanisms of selected functional foods against viral infections with a view on COVID-19: mini review","volume":"5","author":"Haslberger","year":"2020","journal-title":"Funct Foods Health Dis"},{"issue":"1","key":"10.1016\/j.jiph.2020.10.012_bib0505","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jtcme.2018.02.001","article-title":"Mechanism & inhibition kinetics of bioassay-guided fractions of Indian medicinal plants and foods as ACE inhibitors","volume":"9","author":"Khan","year":"2019","journal-title":"Afr J Tradit Complement Altern Med"},{"issue":"3","key":"10.1016\/j.jiph.2020.10.012_bib0510","first-page":"438","article-title":"Plant derived antiviral products for potential treatment of COVID-19: a review","volume":"89","author":"Khan","year":"2020","journal-title":"Phyton Int J Exp Bot"},{"key":"10.1016\/j.jiph.2020.10.012_bib0515","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jiph.2020.05.009","article-title":"Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?","volume":"13","author":"Nilashi","year":"2020","journal-title":"J Infect Public Health"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034120307097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034120307097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:07:48Z","timestamp":1761750468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034120307097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1876034120307097"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2020.10.012","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combating COVID-19: The role of drug repurposing and medicinal plants","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2020.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}